When the demethylation reagent 5-AzadC is applied, the hypermethylation regulation of MEG3 by DNMT1 is significantly inhibited, and uninhibited MEG3 exerts its inhibitory effect on cancer through the inhibition of Notch1 signaling pathway (75). The gene discussed is DNMT1; the disease is cancer.